(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 31571.30 | 35106.70 | -10.07 | 31571.30 | 35106.70 | -10.07 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 1176.80 | 796.60 | 47.73 | 1176.80 | 796.60 | 47.73 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 9750.60 | 11977.80 | -18.59 | 9750.60 | 11977.80 | -18.59 | 40331.70 | 32976.90 | 22.30 |
| Interest | 22.10 | 80.00 | -72.38 | 22.10 | 80.00 | -72.38 | 269.30 | 450.70 | -40.25 |
| PBDT | 9728.50 | 11897.80 | -18.23 | 9728.50 | 11897.80 | -18.23 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1074.60 | 1139.70 | -5.71 | 1074.60 | 1139.70 | -5.71 | 4600.10 | 4686.20 | -1.84 |
| PBT | 8653.90 | 10758.10 | -19.56 | 8653.90 | 10758.10 | -19.56 | 35462.30 | 27840.00 | 27.38 |
| TAX | 2213.90 | 2873.00 | -22.94 | 2213.90 | 2873.00 | -22.94 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -112.50 | -89.30 | 25.98 | -112.50 | -89.30 | 25.98 | -304.00 | -169.20 | 79.67 |
| PAT | 6440.00 | 7885.10 | -18.33 | 6440.00 | 7885.10 | -18.33 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1613.80 | 1613.20 | 0.04 | 1613.80 | 1613.20 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 30.88 | 34.12 | -9.48 | 30.88 | 34.12 | -9.48 | 30.81 | 29.18 | 5.59 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.70 |
| Dr. Reddys Lab | 1236.30 |
| Cipla | 1234.50 |
| Zydus Lifesciences | 938.80 |
| Lupin | 2323.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: